Company NanoGroup S.A.

Equities

NNG

PLNNGRP00011

Biotechnology & Medical Research

Market Closed - Warsaw S.E. 09:25:49 10/05/2024 pm IST 5-day change 1st Jan Change
1.02 PLN -1.45% Intraday chart for NanoGroup S.A. -0.49% +9.91%

Business Summary

Nanogroup SA is a Poland-based company engaged in the biotechnology sector. The Company focuses on the investment in, as well as development of advanced biotechnological projects in the areas of cancer prevention, early diagnosis, targeted cancer therapies and ontological rehabilitation. Its projects portfolio includes NanoVelos, which is responsible for the creation of drug delivery system for proven oncologic medicines to optimize their performance; NanoSanguis, which develops artificial blood to keep alive patients wounded in accidents, as well as a system, named Organ farm, to preserve human organs ex vivo, and NanoThea, which is dedicated to technology that detects cancer cells in early stage.

Sales per Business

PLN in Million2022Weight2023Weight Delta
Medicines and Other Pharmaceutical Products
100.0 %
0 100.0 % 0 100.0 % -98.55%

Sales per region

PLN in Million2022Weight2023Weight Delta
Poland
100.0 %
0 100.0 % 0 100.0 % -98.55%

Managers

Managers TitleAgeSince
Founder 58 12/16/12
Chief Executive Officer 48 09/17/09
Chief Operating Officer - -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 61 28/21/28
Director/Board Member 72 09/17/09
Director/Board Member 54 19/17/19
Director/Board Member 44 17/16/17
Chairman - 28/21/28
Director/Board Member 55 17/16/17
Chief Executive Officer 48 09/17/09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 20,097,459 17,924,818 ( 89.19 %) 0 89.19 %

Company contact information

NanoGroup SA

ul. Rakowiecka 36

02-532, Warsaw

+48 604 74 13 03

http://www.nanogroup.eu
address NanoGroup S.A.(NNG)
  1. Stock Market
  2. Equities
  3. NNG Stock
  4. Company NanoGroup S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW